{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T04:08:15Z","timestamp":1747541295943,"version":"3.40.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"SBI Pharmaceuticals Co., Ltd., Japan."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00380-024-02480-9","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T12:08:55Z","timestamp":1730808535000},"page":"545-556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["5-Aminolevulinic acid combined with ferrous iron ameliorates myocardial ischemia\/reperfusion injury by increasing heme oxygenase-1"],"prefix":"10.1007","volume":"40","author":[{"given":"Nobuhiro","family":"Nakanishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kaikita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Oimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Kuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"issue":"7","key":"2480_CR1","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1161\/CIRCULATIONAHA.109.192666","volume":"121","author":"D Lloyd-Jones","year":"2010","unstructured":"Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J (2010) Executive summary: heart disease and stroke statistics\u20132010 update: a report from the American heart association. Circulation 121(7):948\u2013954","journal-title":"Circulation"},{"issue":"1","key":"2480_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1253\/circj.CJ-09-0619","volume":"74","author":"T Takii","year":"2010","unstructured":"Takii T, Yasuda S, Takahashi J, Ito K, Shiba N, Shirato K, Shimokawa H (2010) Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI registry study. Circ J 74(1):93\u2013100","journal-title":"Circ J"},{"issue":"11","key":"2480_CR3","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMra071667","volume":"357","author":"DM Yellon","year":"2007","unstructured":"Yellon DM, Hausenloy DJ (2007) Myocardial reperfusion injury. N Engl J Med 357(11):1121\u20131135","journal-title":"N Engl J Med"},{"issue":"4","key":"2480_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrcardio.2016.5","volume":"13","author":"DJ Hausenloy","year":"2016","unstructured":"Hausenloy DJ, Yellon DM (2016) Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol 13(4):193\u2013209","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"2480_CR5","first-page":"249","volume":"32","author":"T Gaspar","year":"1999","unstructured":"Gaspar T, Kevers C, Bisbis B, Penel C, Greppin H, Garnier F, Rideau M, Huault C, Billard JP, Foidart JM (1999) Shemin pathway and peroxidase deficiency in a fully habituated and fully heterotrophic non-organogenic sugarbeet callus: an adaptative strategy or the consequence of modified hormonal balances and sensitivities in these cancerous cells? A Rev Reassessment Cell Prolif 32(5):249\u2013270","journal-title":"A Rev Reassessment Cell Prolif"},{"issue":"5","key":"2480_CR6","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","volume":"7","author":"W Stummer","year":"2006","unstructured":"Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392\u2013401","journal-title":"Lancet Oncol"},{"issue":"3","key":"2480_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s11060-018-03080-0","volume":"141","author":"JV Wainwright","year":"2019","unstructured":"Wainwright JV, Endo T, Cooper JB, Tominaga T, Schmidt MH (2019) The role of 5-aminolevulinic acid in spinal tumor surgery: a review. J Neurooncol 141(3):575\u2013584","journal-title":"J Neurooncol"},{"key":"2480_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.intimp.2015.11.034","volume":"37","author":"M Fujino","year":"2016","unstructured":"Fujino M, Nishio Y, Ito H, Tanaka T, Li XK (2016) 5-Aminolevulinic acid regulates the inflammatory response and alloimmune reaction. Int Immunopharmacol 37:71\u201378","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"2480_CR9","doi-asserted-by":"publisher","first-page":"F1149","DOI":"10.1152\/ajprenal.00275.2013","volume":"305","author":"J Hou","year":"2013","unstructured":"Hou J, Cai S, Kitajima Y, Fujino M, Ito H, Takahashi K, Abe F, Tanaka T, Ding Q, Li XK (2013) 5-Aminolevulinic acid combined with ferrous iron induces carbon monoxide generation in mouse kidneys and protects from renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 305(8):F1149-1157","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"2480_CR10","doi-asserted-by":"publisher","first-page":"C665","DOI":"10.1152\/ajpcell.00369.2014","volume":"308","author":"M Zhao","year":"2015","unstructured":"Zhao M, Guo H, Chen J, Fujino M, Ito H, Takahashi K, Abe F, Nakajima M, Tanaka T, Wang J, Huang H, Zheng S, Hei M, Li J, Huang S, Li J, Ma X, Chen Y, Zhao L, Zhuang J, Zhu P, Li XK (2015) 5-aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hypertrophy via activation of the MAPK\/Nrf2\/HO-1 pathway. Am J Physiol Cell Physiol 308(8):C665-672","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"2480_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.healun.2014.09.037","volume":"34","author":"J Hou","year":"2015","unstructured":"Hou J, Zhang Q, Fujino M, Cai S, Ito H, Takahashi K, Abe F, Nakajima M, Tanaka T, Xu J, Zou H, Ding Q, Li XK (2015) 5-Aminolevulinic acid with ferrous iron induces permanent cardiac allograft acceptance in mice via induction of regulatory cells. J Heart Lung Transplant 34(2):254\u2013263","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"2480_CR12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.bbrc.2016.09.156","volume":"479","author":"M Zhao","year":"2016","unstructured":"Zhao M, Zhu P, Fujino M, Nishio Y, Chen J, Ito H, Takahashi K, Nakajima M, Tanaka T, Zhao L, Zhuang J, Li XK (2016) 5-Aminolevulinic acid with sodium ferrous citrate induces autophagy and protects cardiomyocytes from hypoxia-induced cellular injury through MAPK-Nrf-2-HO-1 signaling cascade. Biochem Biophys Res Commun 479(4):663\u2013669","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2480_CR13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.intimp.2014.02.003","volume":"19","author":"Y Nishio","year":"2014","unstructured":"Nishio Y, Fujino M, Zhao M, Ishii T, Ishizuka M, Ito H, Takahashi K, Abe F, Nakajima M, Tanaka T, Taketani S, Nagahara Y, Li XK (2014) 5-Aminolevulinic acid combined with ferrous iron enhances the expression of heme oxygenase-1. Int Immunopharmacol 19(2):300\u2013307","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"2480_CR14","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/ATVBAHA.111.224519","volume":"31","author":"Y Miyazaki","year":"2011","unstructured":"Miyazaki Y, Kaikita K, Endo M, Horio E, Miura M, Tsujita K, Hokimoto S, Yamamuro M, Iwawaki T, Gotoh T, Ogawa H, Oike Y (2011) C\/EBP homologous protein deficiency attenuates myocardial reperfusion injury by inhibiting myocardial apoptosis and inflammation. Arterioscler Thromb Vasc Biol 31(5):1124\u20131132","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"2480_CR15","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jacbts.2017.08.001","volume":"2","author":"M Ishii","year":"2017","unstructured":"Ishii M, Kaikita K, Sato K, Sueta D, Fujisue K, Arima Y, Oimatsu Y, Mitsuse T, Onoue Y, Araki S, Yamamuro M, Nakamura T, Izumiya Y, Yamamoto E, Kojima S, Kim-Mitsuyama S, Ogawa H, Tsujita K (2017) Cardioprotective effects of LCZ696 (Sacubitril\/Valsartan) after experimental acute myocardial infarction. JACC Basic Transl Sci 2(6):655\u2013668","journal-title":"JACC Basic Transl Sci"},{"issue":"11","key":"2480_CR16","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1253\/circj.CJ-18-0135","volume":"82","author":"Y Onoue","year":"2018","unstructured":"Onoue Y, Izumiya Y, Hanatani S, Ishida T, Arima Y, Yamamura S, Kimura Y, Araki S, Ishii M, Nakamura T, Oimatsu Y, Sakamoto K, Yamamoto E, Kojima S, Kaikita K, Tsujita K (2018) Akt1-mediated muscle growth promotes blood flow recovery after hindlimb ischemia by enhancing heme oxygenase-1 in neighboring cells. Circ J 82(11):2905\u20132912","journal-title":"Circ J"},{"issue":"23","key":"2480_CR17","doi-asserted-by":"publisher","first-page":"6388","DOI":"10.1016\/S0021-9258(18)63477-5","volume":"244","author":"R Tenhunen","year":"1969","unstructured":"Tenhunen R, Marver HS, Schmid R (1969) Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem 244(23):6388\u20136394","journal-title":"J Biol Chem"},{"issue":"3","key":"2480_CR18","first-page":"410","volume":"75","author":"R Tenhunen","year":"1970","unstructured":"Tenhunen R, Marver HS, Schmid R (1970) The enzymatic catabolism of hemoglobin: stimulation of microsomal heme oxygenase by hemin. J Lab Clin Med 75(3):410\u2013421","journal-title":"J Lab Clin Med"},{"issue":"4","key":"2480_CR19","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1152\/physrev.00003.2016","volume":"96","author":"A Ayer","year":"2016","unstructured":"Ayer A, Zarjou A, Agarwal A, Stocker R (2016) Heme oxygenases in cardiovascular health and disease. Physiol Rev 96(4):1449\u20131508","journal-title":"Physiol Rev"},{"issue":"11","key":"2480_CR20","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1089\/ars.2013.5675","volume":"20","author":"LL Dunn","year":"2014","unstructured":"Dunn LL, Midwinter RG, Ni J, Hamid HA, Parish CR, Stocker R (2014) New insights into intracellular locations and functions of heme oxygenase-1. Antioxid Redox Signal 20(11):1723\u20131742","journal-title":"Antioxid Redox Signal"},{"issue":"50","key":"2480_CR21","doi-asserted-by":"publisher","first-page":"51769","DOI":"10.1074\/jbc.M409463200","volume":"279","author":"Y Shan","year":"2004","unstructured":"Shan Y, Lambrecht RW, Ghaziani T, Donohue SE, Bonkovsky HL (2004) Role of bach-1 in regulation of heme oxygenase-1 in human liver cells: insights from studies with small interfering RNAS. J Biol Chem 279(50):51769\u201351774","journal-title":"J Biol Chem"},{"issue":"1","key":"2480_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1011-1344(98)00102-X","volume":"44","author":"J van den Boogert","year":"1998","unstructured":"van den Boogert J, van Hillegersberg R, de Rooij FW, de Bruin RW, Edixhoven-Bosdijk A, Houtsmuller AB, Siersema PD, Wilson JH, Tilanus HW (1998) 5-aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration. J Photochem Photobiol B 44(1):29\u201338","journal-title":"J Photochem Photobiol B"},{"key":"2480_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejphar.2018.05.009","volume":"833","author":"H Ito","year":"2018","unstructured":"Ito H, Nishio Y, Hara T, Sugihara H, Tanaka T, Li XK (2018) Oral administration of 5-aminolevulinic acid induces heme oxygenase-1 expression in peripheral blood mononuclear cells of healthy human subjects in combination with ferrous iron. Eur J Pharmacol 833:25\u201333","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"2480_CR24","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1161\/CIRCRESAHA.116.306588","volume":"118","author":"LE Otterbein","year":"2016","unstructured":"Otterbein LE, Foresti R, Motterlini R (2016) Heme oxygenase-1 and carbon monoxide in the heart: the balancing act between danger signaling and pro-survival. Circ Res 118(12):1940\u20131959","journal-title":"Circ Res"},{"issue":"1\u20132","key":"2480_CR25","first-page":"133","volume":"196","author":"HS Sharma","year":"1999","unstructured":"Sharma HS, Das DK, Verdouw PD (1999) Enhanced expression and localization of heme oxygenase-1 during recovery phase of porcine stunned myocardium. Mol Cell Biochem 196(1\u20132):133\u2013139","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"2480_CR26","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1172\/JCI6163","volume":"103","author":"SF Yet","year":"1999","unstructured":"Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, Kobzik L, Wiesel P, Christou H, Kourembanas S, Lee ME (1999) Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 103(8):R23-29","journal-title":"J Clin Invest"},{"issue":"12","key":"2480_CR27","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1161\/01.CIR.103.12.1695","volume":"103","author":"T Yoshida","year":"2001","unstructured":"Yoshida T, Maulik N, Ho YS, Alam J, Das DK (2001) H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: a study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene. Circulation 103(12):1695\u20131701","journal-title":"Circulation"},{"issue":"2","key":"2480_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/hh1401.093314","volume":"89","author":"SF Yet","year":"2001","unstructured":"Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, Ith B, Melo LG, Zhang L, Ingwall JS, Dzau VJ, Lee ME, Perrella MA (2001) Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 89(2):168\u2013173","journal-title":"Circ Res"},{"issue":"17\u201318","key":"2480_CR29","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.lfs.2012.08.014","volume":"91","author":"D Bilbija","year":"2012","unstructured":"Bilbija D, Gravning JA, Haugen F, Attramadal H, Valen G (2012) Protecting the heart through delivering DNA encoding for heme oxygenase-1 into skeletal muscle. Life Sci 91(17\u201318):828\u2013836","journal-title":"Life Sci"},{"issue":"1","key":"2480_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jss.2008.07.044","volume":"155","author":"CH Yeh","year":"2009","unstructured":"Yeh CH, Chen TP, Wang YC, Lin YM, Lin PJ (2009) HO-1 activation can attenuate cardiomyocytic apoptosis via inhibition of NF-kappaB and AP-1 translocation following cardiac global ischemia and reperfusion. J Surg Res 155(1):147\u2013156","journal-title":"J Surg Res"},{"key":"2480_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fphys.2014.00053","volume":"5","author":"R Ben-Amotz","year":"2014","unstructured":"Ben-Amotz R, Bonagura J, Velayutham M, Hamlin R, Burns P, Adin C (2014) Intraperitoneal bilirubin administration decreases infarct area in a rat coronary ischemia\/reperfusion model. Front Physiol 5:53","journal-title":"Front Physiol"},{"issue":"5","key":"2480_CR32","doi-asserted-by":"publisher","first-page":"H1976","DOI":"10.1152\/ajpheart.2001.281.5.H1976","volume":"281","author":"R Foresti","year":"2001","unstructured":"Foresti R, Goatly H, Green CJ, Motterlini R (2001) Role of heme oxygenase-1 in hypoxia-reoxygenation: requirement of substrate heme to promote cardioprotection. Am J Physiol Heart Circ Physiol 281(5):H1976-1984","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"2480_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.yjmcc.2004.10.006","volume":"38","author":"AB Stein","year":"2005","unstructured":"Stein AB, Guo Y, Tan W, Wu WJ, Zhu X, Li Q, Luo C, Dawn B, Johnson TR, Motterlini R, Bolli R (2005) Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol 38(1):127\u2013134","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"2480_CR34","doi-asserted-by":"publisher","first-page":"H643","DOI":"10.1152\/ajpheart.2000.278.2.H643","volume":"278","author":"JE Clark","year":"2000","unstructured":"Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, Motterlini R (2000) Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 278(2):H643\u2013H651","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2480_CR35","unstructured":"Center for Drug Evaluation and Research USFaDA Gleolan (aminolevulinic acid hydrochloride) CLINICAL REVIEW(S). Drugs@FDA, August 8, 2018 Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2017\/209637Orig1s000MedR.pdf (visited on 23 Jan 2023)."},{"key":"2480_CR36","unstructured":"Center for Drug Evaluation and Research USFaDA Gleolan (aminolevulinic acid hydrochloride) NON-CLINICAL REVIEW(S). Drugs@FDA, August 8, 2018 Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2017\/208630Orig1s000PharmR.pdf (visited on 23 Jan 2023)."},{"issue":"3","key":"2480_CR37","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11060-019-03098-y","volume":"141","author":"CG Hadjipanayis","year":"2019","unstructured":"Hadjipanayis CG, Stummer W (2019) 5-ALA and FDA approval for glioma surgery. J Neurooncol 141(3):479\u2013486","journal-title":"J Neurooncol"},{"key":"2480_CR38","doi-asserted-by":"publisher","first-page":"8294805","DOI":"10.1155\/2016\/8294805","volume":"2016","author":"F Al-Saber","year":"2016","unstructured":"Al-Saber F, Aldosari W, Alselaiti M, Khalfan H, Kaladari A, Khan G, Harb G, Rehani R, Kudo S, Koda A, Tanaka T, Nakajima M, Darwish A (2016) The safety and tolerability of 5-aminolevulinic acid phosphate with sodium ferrous citrate in patients with type 2 diabetes mellitus in Bahrain. J Diabetes Res 2016:8294805","journal-title":"J Diabetes Res"},{"issue":"8","key":"2480_CR39","first-page":"1313","volume":"46","author":"JH Kramer","year":"2000","unstructured":"Kramer JH, Lightfoot FG, Weglicki WB (2000) Cardiac tissue iron: effects on post-ischemic function and free radical production, and its possible role during preconditioning. Cell Mol Biol (Noisy-le-grand) 46(8):1313\u20131327","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"2480_CR40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.fob.2014.03.010","volume":"4","author":"K Yamashita","year":"2014","unstructured":"Yamashita K, Hagiya Y, Nakajima M, Ishizuka M, Tanaka T, Ogura S (2014) The effects of the heme precursor 5-aminolevulinic acid (ALA) on REV-ERB\u03b1 activation. FEBS Open Bio 4:347\u2013352","journal-title":"FEBS Open Bio"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02480-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-024-02480-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02480-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T17:57:26Z","timestamp":1747504646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-024-02480-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2480"],"URL":"https:\/\/doi.org\/10.1007\/s00380-024-02480-9","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"type":"print","value":"0910-8327"},{"type":"electronic","value":"1615-2573"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"9 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Koichi Kaikita has received remuneration for lecturing from Bayer Yakuhin, Ltd., Daiichi-Sankyo Co., Ltd., Novartis Pharma AG., and Otsuka Pharmaceutical Co., Ltd.; has received\u00a0trust research\/joint research funds from\u00a0SBI Pharmaceuticals Co., Ltd., Bayer Yakuhin, Ltd.,\u00a0and Daiichi-Sankyo Co., Ltd.; and has received scholarship funds from Abbott Medical Co., Ltd. Dr. Kenichi Tsujita has received remuneration for lecturing from Amgen Astellas BioPharma K.K., Bayer Yakuhin, Ltd., Bristol-Myers K.K., Daiichi Sankyo Co., Ltd., Kowa Pharmaceutical Co. Ltd., MSD K.K., Pfizer Japan Inc., Takeda Pharmaceutical Co., Ltd., ITI Co., Ltd., has received trust research\/joint research funds from Bristol-Myers K.K., Kowa Pharmaceutical Co. Ltd., and has received scholarship funds from Abbott Medical Japan L.L.C, Abbott Vascular Japan Co., Ltd., Boston Scientific Japan K.K., Cardinal Health Japan, Chugai Pharmaceutical Co, Ltd., Fides-one, Inc., Fukuda Denshi Co., Ltd., Japan Lifeline Co., Ltd., Kaneka Medix Co., Ltd., Medtronic Japan Co., Ltd., Mitsubishi Tanabe Pharma, NIHON KOHDEN CORPORATION, NIPRO CORPORATION, Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and TERUMO Co, Ltd.Dr. Kenichi Tsujita is a member of Circulation Journal\u2019s editorial team.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Animal Care and Use Committee of Kumamoto University (Reference number: A29-019) approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval"}}]}}